Peptide Therapy & Growth Hormone

This is the category where marketing most outruns evidence. Prescribing human growth hormone (HGH) for "anti-aging" is prohibited under US federal law (21 U.S.C. § 333(e)) — HGH may only be distributed for specific FDA-approved conditions such as confirmed adult growth hormone deficiency. Popular "peptide" alternatives (sermorelin, ipamorelin, CJC-1295) are compounded products that are not FDA-approved, and the U.S. Food & Drug Administration (FDA) has flagged several of them over compounding safety concerns.

The directory lists 195 clinic profiles tagged for Peptide Therapy & Growth Hormone. Listing tags reflect recorded text and do not confirm a clinic's current services. Eligible clinic price records are shown separately in the price index; website-published and clinic-confirmed sources are labeled separately. Confirm current prices and terms directly with the clinic. Average public Google rating across 35 rated clinics: 4.8★ from 2,078 reviews.

Treatment guide quick facts

How many clinics offer Peptide Therapy & Growth Hormone?

The directory lists 195 clinic profiles tagged for Peptide Therapy & Growth Hormone. Listing inclusion is not certification, and tags may not reflect current services. This is the category where marketing most outruns evidence. Prescribing human growth hormone (HGH) for "anti-aging" is prohibited under US federal law (21 U.S.C. § 333(e)) — HGH may only be distributed for specific FDA-approved conditions such as confirmed adult growth hormone deficiency. Popular "peptide" alternatives (sermorelin, ipamorelin, CJC-1295) are compounded products that are not FDA-approved, and the U.S. Food & Drug Administration (FDA) has flagged several of them over compounding safety concerns.

The legal line most clinics won't explain

HGH (somatropin) occupies a unique place in US law: under 21 U.S.C. § 333(e), distributing or possessing it with intent to distribute for any use other than an FDA-approved indication is a federal offense. Approved uses include confirmed adult growth hormone deficiency (diagnosed by stimulation testing), HIV-associated wasting, and several pediatric conditions. "Anti-aging," "wellness," and "optimization" are not approved uses — a clinic offering HGH for those purposes is describing an illegal prescription.

That legal wall is why the longevity industry pivoted to growth hormone secretagogues — peptides like sermorelin, ipamorelin, and CJC-1295 that stimulate your pituitary to release its own growth hormone. These are typically compounded, which means no FDA review of efficacy, dosing, or purity, and the U.S. Food & Drug Administration (FDA) has placed several popular peptides in its highest-concern category for compounding due to safety uncertainties.

What the evidence actually shows

The study that launched the anti-aging GH industry — Rudman's 1990 New England Journal of Medicine trial in 12 older men — showed increased lean mass and decreased fat over six months. What marketing omits: a 2007 systematic review in Annals of Internal Medicine of GH in the healthy elderly found the body-composition changes were modest, functional benefits were unproven, and side effects were common — soft-tissue edema, joint pain, carpal tunnel syndrome, and increased rates of impaired glucose tolerance and diabetes.

For secretagogue peptides, controlled long-term outcome data in healthy adults are thinner still. Short-term studies show increased GH pulses and IGF-1; translation into meaningful, safe long-term benefit is unproven. Where no governing body or settled guideline exists for a treatment or claim, we state that explicitly — anyone claiming peptides are a proven longevity intervention is ahead of the science.

If you're still considering it

• Rule out true growth hormone deficiency properly: stimulation testing through an endocrinologist, not a single IGF-1 reading used as a sales tool
• Ask exactly which pharmacy compounds the product, in which state it is licensed, and request a certificate of analysis
• Avoid any 'research chemical' or online peptide vendor — purity and dosing are unverifiable
• Monitor fasting glucose and A1c — GH elevation degrades insulin sensitivity
• Ask the prescriber for a written breakdown of medication, consultations, laboratory work, monitoring, and cancellation terms

How much does Peptide Therapy & Growth Hormone cost?

This guide does not calculate a treatment-specific price median. See the price index for eligible clinic price records and source links; confirm current prices and terms directly with the clinic.

Which clinics offer Peptide Therapy & Growth Hormone?

What clinical guidelines and risks govern Peptide Therapy & Growth Hormone?

Important: HGH cannot legally be prescribed for anti-aging in the United States under 21 U.S.C. § 333(e). Peptide secretagogues are not FDA-approved, and several have been flagged by the FDA over compounding safety concerns. This page exists so you can evaluate these programs with the legal and evidence context most marketing leaves out. The study that launched the anti-aging GH industry — Rudman's 1990 New England Journal of Medicine trial in 12 older men — showed increased lean mass and decreased fat over six months. What marketing omits: a 2007 systematic review in Annals of Internal Medicine of GH in the healthy elderly found the body-composition changes were modest, functional benefits were unproven, and side effects were common — soft-tissue edema, joint pain, carpal tunnel syndrome, and increased rates of impaired glucose tolerance and diabetes. For secretagogue peptides, controlled long-term outcome data in healthy adults are thinner still. Short-term studies show increased GH pulses and IGF-1; translation into meaningful, safe long-term benefit is unproven. Where no governing body or settled guideline exists for a treatment or claim, we state that explicitly — anyone claiming peptides are a proven longevity intervention is ahead of the science.

Frequently Asked Questions

Is HGH legal for anti-aging?

No. Federal law (21 U.S.C. § 333(e)) prohibits distributing HGH for anything other than FDA-approved indications such as confirmed adult growth hormone deficiency or HIV-associated wasting. Anti-aging and wellness use is explicitly outside the law, regardless of what a clinic's marketing implies.

Are peptides like sermorelin and ipamorelin FDA-approved?

No. They are compounded products without FDA review of safety, efficacy, or dose consistency. The U.S. Food & Drug Administration (FDA) has placed several popular peptides in its highest-concern category for compounding, citing safety uncertainties. Legality of compounding varies by peptide and pharmacy type.

What's the difference between HGH and peptide secretagogues?

HGH is the hormone itself, injected directly. Secretagogues (sermorelin, ipamorelin, CJC-1295) prompt your pituitary to release more of your own GH. Secretagogues produce smaller, more physiologic GH elevations — and correspondingly smaller effects — with less regulatory restriction but also far less evidence.

How much does peptide therapy cost?

Prices vary by product, pharmacy, prescriber, and included services. This guide does not publish a national estimate; check the price index for eligible clinic-published records and confirm current costs with the prescriber.

What is BPC-157 and does it work?

BPC-157 is a synthetic peptide popular for injury recovery claims. Human trial evidence is essentially absent — the enthusiasm rests on animal studies — and the FDA has flagged it among peptides with safety concerns for compounding. Treat it as experimental.

What are the side effects of raising growth hormone?

In studies of GH in healthy older adults (Annals of Internal Medicine systematic review, 2007): fluid retention and swelling, joint pain, carpal tunnel syndrome, and impaired glucose tolerance progressing to diabetes in some users. Long-term cancer-risk questions remain unresolved. Secretagogues share these concerns in proportion to the GH elevation achieved.

How is real growth hormone deficiency diagnosed?

With growth hormone stimulation testing (such as glucagon or macimorelin testing) interpreted by an endocrinologist, usually in the context of pituitary disease, surgery, or radiation. A low-normal IGF-1 level alone — the common med-spa screening tool — does not establish deficiency.

Why do so many clinics sell peptides if the evidence is weak?

Margins are high, the products feel cutting-edge, and the legal restrictions on HGH pushed demand toward less-regulated alternatives. That's precisely why this directory flags peptide-heavy clinics for extra due diligence — ask for the evidence, the pharmacy's credentials, and the monitoring plan.

Browse all Peptides & HGH clinics

References

1. Effects of Human Growth Hormone in Men over 60 Years Old (Rudman et al., 1990) — New England Journal of Medicine
2. Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly (Liu et al., 2007) — Annals of Internal Medicine (PubMed)
3. 21 U.S.C. § 333(e) — federal restrictions on human growth hormone distribution — U.S. Code (Cornell Law School LII)
4. Human Drug Compounding: FDA oversight and bulk substance evaluations — U.S. Food & Drug Administration

Public rating and review totals are attributed to Google Business Profiles and are not reviews collected by this directory.